- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06892886
Using Immersive Virtual Reality for the Upper Limb Rehabilitation of Post-stroke Subjects
March 17, 2025 updated by: University Hospital of Ferrara
Using Immersive Virtual Reality for the Upper Limb Rehabilitation of Post-stroke Subjects: a Multicenter Randomized Control Trial
Stroke produces brain damages that results in sensory, motor, and cognitive impairments which reduce the patient's quality of life and social participation.
Upper limb recovery is a complex process whose goal is to allow the patients to gain, in part or completely, independence in daily living activities, for that it represents one of the most important rehabilitation focus.
Virtual reality is a fairly recent approach able to simulate concrete movements and functional tasks in a higher dosage compared to other therapies.
It seems that the use of VR could improve limb function, however, the amount of this gain is still unclear because of insufficient evidence.
This study aims at quantitatively investigating the effectiveness of an HMD immersive virtual reality system on the upper limb functioning in subacute stroke survivors.
Study Overview
Study Type
Interventional
Enrollment (Estimated)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sofia Straudi, MD, PhD
- Phone Number: +390532238720
- Email: sofia.straudi@unife.it
Study Locations
-
-
-
Ferrara, Italy, 44124
- Recruiting
- Ferrara University Hospital
-
Principal Investigator:
- Sofia Straudi, MD, PhD
-
Sub-Investigator:
- Andrea Baroni, PT, PhD
-
Contact:
- Sofia Straudi, MD, PhD
- Phone Number: 0532238720
- Email: sofia.straudi@unife.it
-
Sub-Investigator:
- Antonino Casile, PhD
-
Sub-Investigator:
- Giulia Fregna, PT, MSc, PhD student
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- diagnosis of first, ischemic or hemorrhagic, stroke verified by brain imaging within 4 week
- upper limb motor impairment defined by an upper extremity score <55 on the Fugl-Meyer Assessment
Exclusion Criteria:
- neurological conditions in addition to stroke that may affect motor function
- other medical conditions likely to interfere with the ability to safely complete the study protocol
- impaired cognitive functioning that influences the ability to give informed consent
- severe neuropsychological disorders
- visual impairment
- severe upper-limb pain defined as > 7 on the Visual Analogue Scale
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: VR group
All participants will receive an hour of VR training 5 times/week for 4 weeks within the daily rehab routine.
|
Four tasks, uni and bi-manuals, will be proposed for the treatment of the patient's paretic upper limb in virtual-apartment for improving the relevance and the transferability of the movements requested.
Other Names:
|
|
No Intervention: Control group
Participants will receive the usual rehabilitation activities due to their clinical needs (physical therapy, speech therapy, etc) for 5 times/week over 4 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in upper limb impairment
Time Frame: Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
|
Motor recovery will be assessed through the Fugl Meyer Assessment - Upper Extremity
|
Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Spasticity
Time Frame: Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
|
Spasticity grade at the paretic upper limb will be measured with the Ashworth Scale (0-5), in which higher scores are related to more severe muscle hypertonia
|
Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
|
|
Change in Activities of Daily Living
Time Frame: Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
|
Patient's independence will be quantified with the Barthel Index
|
Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
|
|
Change in perceived quality of life
Time Frame: Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
|
Stroke Impact Scale 2.0 will be performed for investigating the perceived quality of life, higher scores indicate better quality of life perceived
|
Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
|
|
Kinematic data
Time Frame: Parameters changes (e.g. hand peak velocities) before (T0) and after (T1) the 4 weeks of treatment
|
Instrumental data of hand movements registered during the sessions (relevant kinematic indexes will be recorded and offline analyzed such as hand trajectories and peak velocity)
|
Parameters changes (e.g. hand peak velocities) before (T0) and after (T1) the 4 weeks of treatment
|
|
Electroencephalogram
Time Frame: Data changes before (T0) and after (T1) the 4 weeks of treatment (4 weeks) and at 6-month follow-up (T2)
|
The EEG signals will be measured by means of a 32-channel cap, according to the International 10-20 system, recorded and monitored by computerized devices.
|
Data changes before (T0) and after (T1) the 4 weeks of treatment (4 weeks) and at 6-month follow-up (T2)
|
|
Treatment satisfaction
Time Frame: After 4 weeks
|
The satisfaction related to the virtual training will be investigated through a specific questionnaire
|
After 4 weeks
|
|
Embodiment
Time Frame: After 4 weeks
|
The embodiment feeling will be analyzed with the Gonzalez-Franco questionnaire
|
After 4 weeks
|
|
Cybersickness
Time Frame: After 4 weeks
|
For monitoring undesirable events the Simulator Sickness Questionnaire will be used
|
After 4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2023
Primary Completion (Estimated)
December 31, 2025
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
January 30, 2023
First Submitted That Met QC Criteria
March 17, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 17, 2025
Last Verified
November 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- VR_STROKE_MULTICENTER
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sub-acute Stroke
-
Riphah International UniversityRecruiting
-
Samsung Medical CenterCompleted
-
University of LahoreNot yet recruitingSub-acute Stroke
-
University of LahoreCompletedSub-acute Non-specific Low Back PainPakistan
-
Stony Brook UniversityUnknownDischarge From Sub-acute Rehabilitation FacilityUnited States
-
Hospital de CrucesCompleted
-
Assistance Publique - Hôpitaux de ParisOrion Corporation, Orion PharmaRecruitingSub-arachnoid HaemorrhageFrance
-
Tanta UniversityCompletedMandibular Sub-condylar FractureEgypt
-
Northwestern Health Sciences UniversityDepartment of Health and Human ServicesCompletedSub-acute and Chronic Back-related Leg PainUnited States
-
Centre Hospitalier Universitaire DijonRecruitingPost-stroke Patient in Acute, Sub-acute Phase or ChronicFrance
Clinical Trials on Virtual Reality
-
Institut National de la Santé Et de la Recherche...RecruitingSchizophrenia | Bipolar DisorderFrance
-
Eskisehir Osmangazi UniversityNot yet recruiting
-
The University of Hong KongCompleted
-
University of PennsylvaniaRecruiting
-
Istanbul University - CerrahpasaCompletedCancer | AnxietyTurkey
-
Cihat OzyılmazCompletedChild | Anxiety | FearTurkey
-
National University of MalaysiaRecruitingPleural EffusionMalaysia
-
Stanford UniversityTerminatedConversion Disorder | Non-epileptic Seizures | Functional Neurological Disorder | Functional Movement Disorder | Psychogenic Movement DisorderUnited States
-
University of WashingtonNational Institutes of Health (NIH); University of Texas; National Institute...Completed
-
Children's Hospital Los AngelesNot yet recruitingProcedural Pain | Procedural Anxiety